{"title":"基质片中苯海明控释制剂的研究","authors":"Lütfi Genç, Hadi Bilaç, Erden Güler","doi":"10.1016/S0031-6865(99)00017-5","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>In this study, controlled release dosage forms of dimenhydrinate were prepared with different polymers as MC, </span>HEC, Carbopol 934, </span>Eudragit<span><span> RLPM and Eudragit NE 30 D at different concentrations (2.5–10%). Direct compression (DC) and wet granulation (WG) techniques were used to prepare the tablets. Magnesium stearate was the </span>lubricant while starch gel was the binder. For the quality control of tablets prepared according to 11 different formulations, weight deviation, hardness, friability, diameter–height ratio, content uniformity of the active substance and in vitro dissolution techniques were performed. Dissolution rate of these tablets was controlled by USP XXII dissolution method and the profile of each tablet was plotted and only for F 5 was evaluated kinetically.</span></p></div>","PeriodicalId":19830,"journal":{"name":"Pharmaceutica acta Helvetiae","volume":"74 1","pages":"Pages 43-49"},"PeriodicalIF":0.0000,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0031-6865(99)00017-5","citationCount":"38","resultStr":"{\"title\":\"Studies on controlled release dimenhydrinate from matrix tablet formulations\",\"authors\":\"Lütfi Genç, Hadi Bilaç, Erden Güler\",\"doi\":\"10.1016/S0031-6865(99)00017-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span><span>In this study, controlled release dosage forms of dimenhydrinate were prepared with different polymers as MC, </span>HEC, Carbopol 934, </span>Eudragit<span><span> RLPM and Eudragit NE 30 D at different concentrations (2.5–10%). Direct compression (DC) and wet granulation (WG) techniques were used to prepare the tablets. Magnesium stearate was the </span>lubricant while starch gel was the binder. For the quality control of tablets prepared according to 11 different formulations, weight deviation, hardness, friability, diameter–height ratio, content uniformity of the active substance and in vitro dissolution techniques were performed. Dissolution rate of these tablets was controlled by USP XXII dissolution method and the profile of each tablet was plotted and only for F 5 was evaluated kinetically.</span></p></div>\",\"PeriodicalId\":19830,\"journal\":{\"name\":\"Pharmaceutica acta Helvetiae\",\"volume\":\"74 1\",\"pages\":\"Pages 43-49\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1999-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S0031-6865(99)00017-5\",\"citationCount\":\"38\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutica acta Helvetiae\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0031686599000175\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutica acta Helvetiae","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0031686599000175","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 38
摘要
以不同浓度(2.5 ~ 10%)的聚合物MC、HEC、Carbopol 934、Eudragit RLPM和Eudragit NE 30d制备了苯海明控释剂型。采用直接压缩(DC)和湿造粒(WG)技术制备片剂。硬脂酸镁为润滑剂,淀粉凝胶为粘合剂。采用重量偏差、硬度、脆度、径高比、原料药含量均匀度及体外溶出度技术对11种不同配方制备的片剂进行质量控制。采用USP XXII溶出度法控制其溶出度,绘制各片的溶出度曲线,仅对f5进行动力学评价。
Studies on controlled release dimenhydrinate from matrix tablet formulations
In this study, controlled release dosage forms of dimenhydrinate were prepared with different polymers as MC, HEC, Carbopol 934, Eudragit RLPM and Eudragit NE 30 D at different concentrations (2.5–10%). Direct compression (DC) and wet granulation (WG) techniques were used to prepare the tablets. Magnesium stearate was the lubricant while starch gel was the binder. For the quality control of tablets prepared according to 11 different formulations, weight deviation, hardness, friability, diameter–height ratio, content uniformity of the active substance and in vitro dissolution techniques were performed. Dissolution rate of these tablets was controlled by USP XXII dissolution method and the profile of each tablet was plotted and only for F 5 was evaluated kinetically.